SVRA vs VTRS

Analysts rate Savara Inc.

(SVRA) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Savara Inc.

(SVRA) delivered a total return of +216. 6%, compared to +40. 3% for Viatris Inc. (VTRS). Over 10 years, the gap is even starker: SVRA returned -40. 3% versus VTRS's -52. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Viatris Inc.

(VTRS) is the lower-risk stock at 0. 94β versus Savara Inc. 's 1. 10β — meaning SVRA is approximately 17% more volatile than VTRS relative to the S&P 500. On balance sheet safety, Savara Inc. (SVRA) carries a lower debt/equity ratio of 16% versus 100% for Viatris Inc. — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: Savara Inc.

grew EPS -45. 5% year-over-year, compared to -466. 0% for Viatris Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Savara Inc.

(SVRA) is the more profitable company, earning 0. 0% net margin versus -24. 6% for Viatris Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SVRA leads at 0. 0% versus -18. 6% for VTRS. At the gross margin level — before operating expenses — VTRS leads at 35. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for SVRA: 93.

8% to $10. 00.

In this comparison, VTRS (2.

8% yield) pays a dividend. SVRA does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Viatris Inc.

(VTRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 2. 8% yield). Both have compounded well over 10 years (VTRS: -52. 1%, SVRA: -40. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

VTRS pays a dividend while SVRA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.